CUSIP: 92852W204
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
20,997,421
-
Share change
-
+8,693,430
-
Total reported value
-
$76,854,878
-
Put/Call ratio
-
100%
-
Price per share
-
$3.66
-
Number of holders
-
52
-
Value change
-
+$31,793,081
-
Number of buys
-
37
-
Number of sells
-
10
Quarterly Holders Quick Answers
What is CUSIP 92852W204?
CUSIP 92852W204 identifies VIVE - VIVEVE MED INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 92852W204:
Institutional Holders of VIVEVE MED INC - COM NEW (VIVE) as of Q1 2018
As of 31 Mar 2018,
VIVEVE MED INC - COM NEW (VIVE) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,997,421 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, Nantahala Capital Management, LLC, RTW INVESTMENTS, LP, HighTower Advisors, LLC, venBio Select Advisor LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., Polar Capital LLP, BlackRock Inc., and Wexford Capital LP.
This page lists
52
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.